Microgravity is known to alter the muscles, bones, the immune system and cognition, but little is known about its specific impact on the brain.
Biotech FogPharma raises $145 million in anticipation of more clinical trials, pharma partnerships
Oncology startup FogPharma just closed a $145 million Series E round, the company confirmed, reaching a late stage of financing that few other biotechs have